Onconetix, Inc. — Form D
Onconetix, Inc. of CINCINNATI, OH, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-07. The offering totals $13.0M, of which $13.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-07
- Form: D
- Accession: 0001465818-25-000010
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $13.0M
- Amount sold: $13.0M
- Minimum investment: $209K
- Investors: 11
- Date of first sale: 2025-09-22
- Security types: equity, debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-560082
Issuer
- Name: Onconetix, Inc.
- CIK: 0001782107
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 201 E. FIFTH STREET, CINCINNATI, OH, 45202
- Phone: 513-620-4101
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Thomas Meier | Director | Cincinnati, OH |
| Andrew Oakley | Director | Cincinnati, OH |
| Timothy Ramdeen | Director | Cincinnati, OH |
| Simon Tarsh | Director | Cincinnati, OH |
| Karina Fedasz | Executive Officer | Phoenix, AZ |
| James Sapirstein | Director | Cincinnati, OH |
| Ajit Singh | Director | Palo Alto, CA |
| Ralph Schiess | Executive Officer | Cincinnati, OH |
| Joseph Hernandez | Executive Officer | Cincinnati, OH |
Other filings by this issuer (2)
More